The National Accreditation Board for Testing and Calibration Laboratories (NABL) on December 18, 2024, issued the Guidance document: Medical Laboratories.
The following has been stated namely: -
• The document provides guidance for medical testing laboratories on sample collection, accreditation scope, lot verification, result reporting algorithms, competency assessment, and sample stability for clinical biochemistry.
• It provides guidelines for scope preparation requiring using IQC data for %CV and MU, segregating test profiles, and specifying enzyme methodologies with appropriate testing ranges.
• It outlines guidelines for lot verification including parallel testing of new and old QC lots, calculating new means and ranges, and verifying reagent acceptability through patient samples or controls.
Detailed notification is attached below.
[Notification no. - NABL 112B]
